IRON-DEFICIENCY AND INTESTINAL ALUMINUM ABSORPTION - IMPLICATIONS FOR ERYTHROPOIETIN AND DEFEROXAMINE THERAPY

被引:2
作者
CANNATA, JB
ALONSOSUAREZ, M
FERNANDEZMARTIN, JL
DIAZLOPEZ, B
机构
[1] Bone and Mineral Research Unit, Hospital General de Asturias, Oviedo
关键词
D O I
10.1111/j.1525-139X.1991.tb00095.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:224 / 226
页数:3
相关论文
共 25 条
[1]
Parkinson IS, Ward MK, Feest TG, Fawcett RWP, Kerr DNS, Fracturing dialysis osteodistrophy and dialysis encephalopathy: An epidemiological study, Lancet, 1, pp. 406-409, (1979)
[2]
Drueke T, Aluminum toxicity in chronic renal failure, J Nephrol, 2, pp. 49-59, (1989)
[3]
Cannata JB, Aluminium‐induced toxicity in dialysis patients: Role of water and other sources on its pathogenesis, Water treatment monograph, pp. 49-67, (1988)
[4]
Ott SM, Sources of aluminium, Aluminium and Renal Failure, pp. 189-202, (1990)
[5]
Cannata JB, Diaz Lopez JB, The diagnosis of aluminium toxicity, Aluminium and Renal Failure, pp. 287-308, (1990)
[6]
Kaehny WD, Hegg AP, Alfrey AC, Gastrointestinal absorption of aluminium from aluminium‐containing antacids, N Engl J Med, 296, pp. 1389-1390, (1977)
[7]
Cannata JB, Briggs JD, Junor BJR, Fell GS, Aluminium hydroxide intake: Real risk of aluminium toxicity, Br Med J, 236, pp. 1937-1939, (1983)
[8]
Alfrey AC, Gastrointestinal absorption of aluminium, Clin Neprhol, 24, pp. 584-587, (1985)
[9]
Cannata JB, Serrano M, Fernandez SI, Fernandez MJL, Olaizola I, Minimizing the risk of oral aluminium exposure in chronic renal failure, Contrib Nephrol, 71, pp. 81-89, (1989)
[10]
Drueke T, Lacour B, Touam M, Basile C, Bourdon R, Oral aluminium administration to uremic, hyperparathyroid, or vitamin D‐supplemented rats, Nephron, 39, pp. 10-17, (1985)